Sacubitril/Valsartan May Alter Trajectory of Preclinical HFpEF Sacubitril/Valsartan May Alter Trajectory of Preclinical HFpEF

The combination was linked to greater changes in left atrial volume index on MRI than valsartan alone in the setting of reduced filling pressures in a phase 2 study.Medscape Medical News

Source: Medscape Cardiology Headlines - November 24, 2021 Category: Cardiology Tags: Cardiology News Source Type: news